<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">345814</id>
  <title nil="true"/>
  <common-name>7,9-dibromo-5-(4-methylphenyl)-2-naphthalen-2-yl-5,10b-dihydro-1h-pyrazolo[1,5-c][1,3]benzoxazine</common-name>
  <description>7,9-dibromo-5-(4-methylphenyl)-2-naphthalen-2-yl-5,10b-dihydro-1h-pyrazolo[1,5-c][1,3]benzoxazine is a chemical compound with the formula C27H20Br2N2O. With an average molecular weight of 548.30 g/mol, 7,9-dibromo-5-(4-methylphenyl)-2-naphthalen-2-yl-5,10b-dihydro-1h-pyrazolo[1,5-c][1,3]benzoxazine is a heavy molecule.</description>
  <cas nil="true"/>
  <pubchem-id>45054377</pubchem-id>
  <chemical-formula>C27H20Br2N2O</chemical-formula>
  <weight>548.3</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T08:48:53Z</created-at>
  <updated-at type="dateTime">2026-08-31T08:48:53Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CC1=CC=C(C=C1)C2N3C(CC(=N3)C4=CC5=CC=CC=C5C=C4)C6=C(O2)C(=CC(=C6)Br)Br</moldb-smiles>
  <moldb-formula>C27H20Br2N2O</moldb-formula>
  <moldb-inchi>InChI=1S/C27H20Br2N2O/c1-16-6-8-18(9-7-16)27-31-25(22-13-21(28)14-23(29)26(22)32-27)15-24(30-31)20-11-10-17-4-2-3-5-19(17)12-20/h2-14,25,27H,15H2,1H3</moldb-inchi>
  <moldb-inchikey>JTEUIEVLDJGUMW-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">545.99424</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>7.8</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM341707</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>7,9-dibromo-5-(4-methylphenyl)-2-naphthalen-2-yl-5,10b-dihydro-1h-pyrazolo[1,5-c][1,3]benzoxazine</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Benzoxazines</klass>
  <subklass nil="true"/>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0296168</sync-id>
  <structure-inchikey>JTEUIEVLDJGUMW-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>80000000000000000000000000000000000000000800000001800000110000a0000000000000000200000000000002000000000000000040000000000000000000080000400000000000200000000000000800000000000020000800102000000000000000000004000000000110000800400020100008000000001000000101102000040000001800000000000000000800000000100000000000000000001000200008000000000000000080000000000008000000000000000000000001000000000000000000000000100000080000000000000002000000200000000000010000100000001000040000000000080080000400000000000000000000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAgAAAAJQAAAIABBgBgAAAAAQMGQCgAAAAD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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:44:44Z</structure-indexed-at>
</compound>
